Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits: An Immunologic Crossroads
Glomerular Diseases · 12.03.2026 · 6 (1) · 125-138
DOI: 10.1159/000551513 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glomerular Diseases, online erschienen am 12.03.2026. Verfasst von Eric Magliulo und 4 weiteren Autor:innen. Beteiligte Einrichtung: Methodist Physicians Clinic Nephrology, Omaha, NE, USA. Die Arbeit nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background: Proliferative glomerulonephritis with monoclonal immunoglobulin deposits (PGNMID) is largely regarded as a form of monoclonal gammopathy of renal significance; however, 70–80% of cases lack evidence of an associated monoclonal lymphoproliferative disorder. Emerging evidence suggests it is a shared clinicopathologic manifestation of multiple, distinct disease etiologies including infection, autoimmunity, complement dysregulation, and neoplasia. Development of a more precise, etiology-based system of classification is hindered by limitations in adequately characterizing the clonal nature of monotypic deposits in renal tissue. Furthermore, the current body of evidence evaluating effective treatment options for PGNMID is limited by retrospective data, small sample sizes, and variability in treatment regimens. As a result, treatment strategies are largely extrapolated from established therapies used in overt hematologic malignancies. Summary: In this review, we discuss the classification, pathogenesis, clinicopathologic features, diagnostic challenges, and treatment approach for PGNMID. Key Message: The heterogenous nature and lack of consensus to guide the management of PGNMID highlights the need for an individualized and multidisciplinary team approach involving nephrologists, hematologists, and nephropathologists. Practicing clinicians need to be aware of the limitations of diagnostic tools used in routine clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Methodist Physicians Clinic Nephrology, Omaha, NE, USA.
- Department of Internal Medicine, Division of Hematology and Oncology, Stormont Vail Health, Topeka, KS, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.
- Department of Internal Medicine, Division of Hematology and Oncology, University of Nebraska Medical Center, Omaha, NE, USA.
- Department of Internal Medicine, Division of Nephrology, University of Nebraska Medical Center, Omaha, NE, USA.
Zitieren
APA
Magliulo, E., Alali, Y., Bu, L., Wildes, T., & Ravipati, P. (2026). Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits: An Immunologic Crossroads. Glomerular Diseases, 6(1), 125-138. https://doi.org/10.1159/000551513
Vancouver
Magliulo E, Alali Y, Bu L, Wildes T, Ravipati P. Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits: An Immunologic Crossroads. Glomerular Diseases. 2026;6(1):125-138. doi:10.1159/000551513
BibTeX
@article{Magliulo2026,
author = {Magliulo, Eric and Alali, Yaman and Bu, Lihong and Wildes, Tanya and Ravipati, Prasanth},
title = {Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits: An Immunologic Crossroads},
journal = {Glomerular Diseases},
year = {2026},
volume = {6},
number = {1},
pages = {125--138},
doi = {10.1159/000551513}
}
EUVIMED